PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre
N.N. Alexandrov National Cancer Centre
N.N. Alexandrov National Cancer Centre
Tata Memorial Hospital
Shanghai Gynecologic Oncology Group
Tata Memorial Hospital
Tata Memorial Hospital
Queensland Centre for Gynaecological Cancer
Tata Memorial Hospital
Tata Memorial Hospital
Tata Memorial Hospital
National Cancer Center, Korea
Tata Memorial Hospital
Tata Memorial Hospital
Tata Memorial Hospital
Tata Memorial Hospital
Tata Memorial Hospital
Taipei Veterans General Hospital, Taiwan
Kenyatta National Hospital
Institut de Recherche pour le Developpement
Queensland Centre for Gynaecological Cancer
Gaziosmanpasa Research and Education Hospital
Sheba Medical Center
Shanghai Gynecologic Oncology Group
Umraniye Education and Research Hospital
National Institute of Cancerología
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Dharmais National Cancer Center Hospital
Anhui Provincial Hospital
National Cancer Center, Korea
Azienda USL Reggio Emilia - IRCCS
Ankara Etlik City Hospital
Instituto Nacional de Cancerologia, Columbia
Ankara Etlik City Hospital
Azienda USL Reggio Emilia - IRCCS
NHS Grampian
Tel-Aviv Sourasky Medical Center
Anhui Provincial Hospital
Shanghai Gynecologic Oncology Group
Azienda USL Reggio Emilia - IRCCS
National Institute of Cancerología
Azienda USL Reggio Emilia - IRCCS
Shanghai Gynecologic Oncology Group
National Institute of Cancerología
National Institute of Cancerología
National Institute of Cancerología
National Institute of Cancerología
National Institute of Cancerología
Izmir City Hospital
Sheikh Zayed Medical College
Shanghai Gynecologic Oncology Group